JP2009510037A5 - - Google Patents

Download PDF

Info

Publication number
JP2009510037A5
JP2009510037A5 JP2008532862A JP2008532862A JP2009510037A5 JP 2009510037 A5 JP2009510037 A5 JP 2009510037A5 JP 2008532862 A JP2008532862 A JP 2008532862A JP 2008532862 A JP2008532862 A JP 2008532862A JP 2009510037 A5 JP2009510037 A5 JP 2009510037A5
Authority
JP
Japan
Prior art keywords
formula
compound
pyran
dihydro
piperidinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008532862A
Other languages
English (en)
Japanese (ja)
Other versions
JP5209479B2 (ja
JP2009510037A (ja
Filing date
Publication date
Priority claimed from GBGB0519966.6A external-priority patent/GB0519966D0/en
Priority claimed from GB0602853A external-priority patent/GB0602853D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/003585 external-priority patent/WO2007036711A1/en
Publication of JP2009510037A publication Critical patent/JP2009510037A/ja
Publication of JP2009510037A5 publication Critical patent/JP2009510037A5/ja
Application granted granted Critical
Publication of JP5209479B2 publication Critical patent/JP5209479B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008532862A 2005-09-30 2006-09-27 Ｍ１受容体にて活性を有するベンゾイミダゾロン類 Expired - Fee Related JP5209479B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB0519966.6A GB0519966D0 (en) 2005-09-30 2005-09-30 Compounds
GB0519966.6 2005-09-30
GB0602853A GB0602853D0 (en) 2006-02-13 2006-02-13 Compounds
GB0602853.4 2006-02-13
PCT/GB2006/003585 WO2007036711A1 (en) 2005-09-30 2006-09-27 BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR

Publications (3)

Publication Number Publication Date
JP2009510037A JP2009510037A (ja) 2009-03-12
JP2009510037A5 true JP2009510037A5 (https=) 2009-11-12
JP5209479B2 JP5209479B2 (ja) 2013-06-12

Family

ID=37398768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008532862A Expired - Fee Related JP5209479B2 (ja) 2005-09-30 2006-09-27 Ｍ１受容体にて活性を有するベンゾイミダゾロン類

Country Status (4)

Country Link
US (1) US8288413B2 (https=)
EP (1) EP1937670A1 (https=)
JP (1) JP5209479B2 (https=)
WO (1) WO2007036711A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007036718A2 (en) * 2005-09-30 2007-04-05 Glaxo Group Limited Compounds which have activity at m1 receptor and their uses in medicine
US8283364B2 (en) * 2005-09-30 2012-10-09 Glaxo Group Limited Compounds which have activity at M1 receptor and their uses in medicine
WO2007036711A1 (en) 2005-09-30 2007-04-05 Glaxo Group Limited BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
GB0605785D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0706164D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706165D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706174D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706170D0 (en) * 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
JP2010539218A (ja) * 2007-09-20 2010-12-16 グラクソ グループ リミテッド Ｍ１受容体にて活性を有する化合物および医薬としてのそれらの使用
WO2009037294A1 (en) * 2007-09-20 2009-03-26 Glaxo Group Limited Compounds which have activity at m1 receptor and their uses in medicine
GB0718415D0 (en) * 2007-09-20 2007-10-31 Glaxo Group Ltd Compounds
CN103497146B (zh) * 2013-09-27 2016-04-13 山东大学 2-(n-芳甲基哌啶-4-氨基)-4-(取代苯酚)苯环衍生物及其制备方法与应用
CN106045916B (zh) * 2016-05-31 2018-08-31 江苏之江化工有限公司 一种咪唑酮类化合物的合成方法
CN109206323A (zh) * 2017-07-07 2019-01-15 上海现代制药股份有限公司 一种萘胺药物中间体的制备方法

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161645A (en) * 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives
US4292321A (en) * 1979-05-24 1981-09-29 Warner-Lambert Company 1,3,8-Triazaspirodecane-4-ones, pharmaceutical compositions thereof and method of use thereof
DE3124366A1 (de) * 1981-06-20 1982-12-30 Hoechst Ag, 6000 Frankfurt N-oxacyclyl-alkylpiperidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und deren verwendung
DE4040300A1 (de) 1990-12-17 1992-07-02 Leifeld Gmbh & Co Drueckmaschine mit wenigstens einem rollenhalter
JP3916093B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 光学活性イミダゾリジノン誘導体とその製造方法
JP2002515008A (ja) * 1994-10-27 2002-05-21 メルク エンド カンパニー インコーポレーテッド ムスカリン・アンタゴニスト
US5574044A (en) * 1994-10-27 1996-11-12 Merck & Co., Inc. Muscarine antagonists
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
AU7478396A (en) 1995-10-31 1997-05-22 Merck & Co., Inc. Muscarine agonists
US5718912A (en) * 1996-10-28 1998-02-17 Merck & Co., Inc. Muscarine agonists
US5977134A (en) * 1996-12-05 1999-11-02 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US6162804A (en) * 1997-09-26 2000-12-19 Merck & Co., Inc. Tyrosine kinase inhibitors
AU2307999A (en) 1997-12-23 1999-07-12 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
US6699880B1 (en) 1999-10-13 2004-03-02 Banyu Pharmaceutical Co., Ltd. Substituted imidazolidinone derivatives
SE9904652D0 (sv) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
WO2001057019A1 (en) * 2000-02-01 2001-08-09 Cor Therapeutics, Inc. INDALONE AND BENZIMIDAZOLONE INHIBITORS OF FACTOR Xa
EP1385518B1 (en) * 2001-04-18 2008-08-06 Euro-Celtique S.A. Benzimidazolone compounds
JPWO2002085890A1 (ja) * 2001-04-20 2004-08-12 萬有製薬株式会社 ベンズイミダゾロン誘導体
WO2004089942A2 (en) 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
BR0213611A (pt) * 2001-10-02 2005-12-20 Acadia Pharm Inc Composto, composição farmacêutica, seus usos, método para aumentar a atividade de um receptor colinérgico, métodos para tratamento ou prevenção de distúrbio mental, dor, pressão intraocular aumentada e progressão ou formação de placas amilóides
US6951849B2 (en) * 2001-10-02 2005-10-04 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
CA2465328C (en) * 2001-11-01 2011-06-14 Michael Francis Gross Piperidines
JP4056977B2 (ja) 2002-03-29 2008-03-05 田辺三菱製薬株式会社 睡眠障害治療薬
EP1515722A4 (en) 2002-06-17 2006-06-21 Merck & Co Inc OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCCULAR HYPERTONIA
US7645771B2 (en) 2002-12-13 2010-01-12 Smithkline Beecham Corp. CCR5 antagonists as therapeutic agents
WO2005009996A1 (en) * 2003-07-23 2005-02-03 Wyeth Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands
UA86204C2 (uk) * 2003-09-03 2009-04-10 Пфайзер Инк. Сполуки бензімідазолону, які мають 5-нт4 рецепторну агоністичну активність
ES2318556T3 (es) * 2004-11-02 2009-05-01 Pfizer, Inc. Derivados de sulfonil bencimidazol.
US7300947B2 (en) * 2005-07-13 2007-11-27 Banyu Pharmaceutical Co., Ltd. N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
WO2007036711A1 (en) 2005-09-30 2007-04-05 Glaxo Group Limited BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
WO2007036718A2 (en) 2005-09-30 2007-04-05 Glaxo Group Limited Compounds which have activity at m1 receptor and their uses in medicine
US8283364B2 (en) * 2005-09-30 2012-10-09 Glaxo Group Limited Compounds which have activity at M1 receptor and their uses in medicine
CA2662333C (en) 2006-09-08 2013-12-31 The Gillette Company Toothbrush with multiple bristle states
GB0706190D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706170D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706164D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706165D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706174D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706167D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706189D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706187D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706173D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706168D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds
GB0706188D0 (en) 2007-03-29 2007-05-09 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
JP2009510037A5 (https=)
JP2009510041A5 (https=)
JP2009512635A5 (https=)
AU2023201399B2 (en) Modulators of the integrated stress pathway
AU2018282336B2 (en) Trk-inhibiting compound
JP5795402B2 (ja) 新規抗血小板薬
AU2012344041B2 (en) New bicyclic dihydroisoquinoline-1-one derivatives
KR100731276B1 (ko) 호흡기 신시티움 바이러스 복제 억제제
CN100352816C (zh) 伤害感受肽类似物
JP4357965B2 (ja) メタボトロピックグルタミン酸受容体−５のヘテロアリール置換ピロールモジュレーター
JP5313865B2 (ja) ベンゾイミダゾール化合物およびその医薬用途
JP4299139B2 (ja) 代謝型グルタミン酸受容体−５のヘテロアリール置換トリアゾールモジュレータ
CN1358182A (zh) 呼吸道合胞病毒复制抑制剂
US20130157995A1 (en) Nicotine compounds and analogs thereof, synthetic methods of making compounds, and methods of use
JP2008513496A5 (https=)
JP2009530348A5 (https=)
CA2624504A1 (en) Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
TW200401641A (en) 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
JP2005289816A (ja) ベンズイミダゾール誘導体
TW201018682A (en) Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
EP2794612B1 (en) 2-(pyridin-2yl)-1,7-diaza-spiro[4.4]nonane-6-one compounds as voltage-gated sodium channels modulators
CN100441182C (zh) 伤害感受肽化合物
RU2332414C2 (ru) Производные аминобензимидазолов в качестве ингибиторов репликации респираторного синцитиального вируса
JP2009513513A (ja) Ｏｒｌ−１受容体リガンドとしての置換インドール
CN1246859A (zh) 用作精神抑制剂的(4－哌啶基)－1h－2－苯并吡喃衍生物